1 1453 117 INFLUENCE OF PRANAYAMAS AND YOGA-ASANAS ON SERUM INSULIN, BLOOD GLUCOSE AND LIPID PROFILE IN TYPE 2 DIABETES. A DISTINGUISHABLE FEATURE OF TYPE 2 DIABETES BESIDES HYPERGLYCEMIA AND DERANGED LIPID PROFILE IS AN IMPAIRED INSULIN SECRETION, PERIPHERAL INSULIN RESISTANCE AND OBESITY WHICH HAS BECOME A MAJOR HEALTH CONCERN WORLDWIDE. INDIA WITH AN ESTIMATED 31MILLION DIABETICS IN 2000 AND 79MLLIONS BY THE YR 2030 HAS THE HIGHEST NUMBER OF TYPE 2 DIABETICS IN THE WORLD. IN THIS STUDY, WE AIMED TO SEE IF YOGA-ASANAS AND PRANAYAMAS HAVE ANY INFLUENCE IN MODIFYING CERTAIN BIOCHEMICAL PARAMETERS. SIXTY PATIENTS OF UNCOMPLICATED TYPE 2 DIABETES (AGE 35-60 YRS OF 1-10 YRS DURATION) WERE DIVIDED INTO TWO GROUPS: GROUP 1 (N=30): PERFORMED YOGA ALONG WITH THE CONVENTIONAL HYPOGLYCEMIC MEDICINES AND GROUP 2 (N=30): PATIENTS WHO ONLY RECEIVED CONVENTIONAL MEDICINES. DURATION OF THE STUDY WAS 45 DAYS. BASAL RECORDINGS OF BLOOD GLUCOSE (FASTING AND POST-PRANDIAL), LIPID PROFILE AND SERUM INSULIN WERE TAKEN AT THE TIME OF RECRUITMENT AND THE SECOND READING AFTER FORTY FIVE DAYS. RESULTS SHOWED A SIGNIFICANT IMPROVEMENT IN ALL THE BIOCHEMICAL PARAMETERS IN GROUP 1 WHILE GROUP 2 SHOWED SIGNIFICANT IMPROVEMENT IN ONLY FEW PARAMETERS, THUS SUGGESTING A BENEFICIAL EFFECT OF YOGA REGIMEN ON THESE PARAMETERS IN DIABETIC PATIENTS. 2008 2 959 33 EFFECTS OF A YOGA INTERVENTION ON LIPID PROFILES OF DIABETES PATIENTS WITH DYSLIPIDEMIA. OBJECTIVE: THE PRESENT STUDY WAS CONDUCTED TO ASSESS THE EFFECTIVENESS OF YOGA IN THE MANAGEMENT OF DYSLIPIDEMIA IN PATIENTS OF TYPE 2 DIABETES MELLITUS. METHODS: THIS RANDOMIZED PARALLEL STUDY WAS CARRIED OUT IN MEDICAL COLLEGE TRIVANDRUM, KERALA, INDIA. HUNDRED TYPE 2 DIABETICS WITH DYSLIPIDEMIA WERE RANDOMIZED INTO CONTROL AND YOGA GROUPS. THE CONTROL GROUP WAS PRESCRIBED ORAL HYPOGLYCEMIC DRUGS. THE YOGA GROUP PRACTICED YOGA DAILY FOR 1 H DURATION ALONG WITH ORAL HYPOGLYCEMIC DRUGS FOR 3 MONTHS. THE LIPID PROFILES OF BOTH THE GROUPS WERE COMPARED AT THE START AND AT THE END OF 3 MONTHS. RESULTS: AFTER INTERVENTION WITH YOGA FOR A PERIOD OF 3 MONTHS THE STUDY GROUP SHOWED A DECREASE IN TOTAL CHOLESTEROL, TRIGLYCERIDES AND LDL, WITH AN IMPROVEMENT IN HDL. CONCLUSION: YOGA, BEING A LIFESTYLE INCORPORATING EXERCISE AND STRESS MANAGEMENT TRAINING, TARGETS THE ELEVATED LIPID LEVELS IN PATIENTS WITH DIABETES THROUGH INTEGRATED APPROACHES. 2013 3 810 39 EFFECT OF YOGA ON BLOOD GLUCOSE LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. INTRODUCTION: IN VIEW OF PEOPLE EMBRACING SEDENTARY LIFE STYLE, AND THE EFFECTIVENESS OF TREATMENT BECOMING LESS, THE ROLE OF REGULAR EXERCISE ESPECIALLY 'YOGA' SEEMS TO BE A BENEFICIAL AND ECONOMICAL ADJUVANT IN THE MANAGEMENT OF THE TYPE 2 DIABETES MELLITUS (T2DM). OBJECTIVES: TO ASSESS THE BENEFICIAL EFFECTS OF YOGA ON BLOOD GLUCOSE LEVELS IN NORMAL AND T2DM VOLUNTEERS. MATERIALS AND METHODS: A PROSPECTIVE CASE-CONTROL STUDY WAS CONDUCTED IN THE DEPARTMENT OF PHYSIOLOGY AND DIABETIC CLINIC OF A TERTIARY CARE TEACHING HOSPITAL OVER PERIOD OF TWO YEARS. THE STUDY SUBJECTS CONSISTED OF 30 MALE DIABETIC PATIENTS ATTENDING DIABETIC CLINIC AND 30 NON-DIABETIC MALE VOLUNTEERS CONSTITUTED CONTROL GROUP. THE PATIENTS IN THE AGE GROUP OF 36 TO 55 YEARS WITH T2DM OF AT LEAST ONE YEAR DURATION AND THOSE ON DIABETIC DIET AND ORAL HYPOGLYCEMIC AGENTS WERE INCLUDED IN THE STUDY GROUP. THE AGE MATCHED HEALTHY MALE VOLUNTEERS WHO HAD COME TO JOIN YOGA TRAINING AT YOGA CENTRE WERE INCLUDED IN THE CONTROL GROUP. ALL THE PARTICIPANTS WERE TRAINED BY YOGA EXPERTS AND SUBJECTED TO REGULAR PRACTICE UNDER SUPERVISION FOR SIX MONTHS. IN ALL THE PARTICIPANTS FASTING (FBS) AND POST-PRANDIAL BLOOD SUGAR (PPBS) WAS ESTIMATED BEFORE, DURING (AT THREE MONTHS) AND AFTER (SIX MONTHS) YOGA TRAINING. PAIRED STUDENT T-TEST WAS USED TO ESTIMATE DIFFERENCE IN MEANS CALCULATED BEFORE AND AFTER YOGA TRAINING IN A SAME GROUP. A P-VALUE OF <0.05 WAS CONSIDERED AS STATISTICALLY SIGNIFICANT. RESULTS: THE DISTRIBUTION OF AGE, MEAN HEIGHT AND MEAN WEIGHT AMONG BOTH THE GROUPS WERE COMPARABLE. THE REDUCTION IN MEAN VALUES OF FBS AND PPBS AT THE END OF SIX MONTHS WAS HIGHLY SIGNIFICANT (P <0.001) IN BOTH THE GROUPS WHEN COMPARED WITH THE MEAN VALUES BEFORE AND DURING (THREE MONTHS) YOGA PRACTICE. THE REDUCTION IN THESE VALUES AT THREE MONTHS DURING YOGA WAS HIGHLY SIGNIFICANT IN T2DM GROUP WHEN COMPARED WITH MEAN VALUES BEFORE YOGA (P <0.001), BUT IT WAS INSIGNIFICANT (P<0.05) IN CONTROL GROUP. CONCLUSION: THE RESULTS OF THE PRESENT STUDY DEMONSTRATED THAT THE YOGA IS EFFECTIVE IN REDUCING THE BLOOD GLUCOSE LEVELS IN PATIENTS WITH T2DM. 2015 4 876 40 EFFECT OF YOGA THERAPY ON REACTION TIME, BIOCHEMICAL PARAMETERS AND WELLNESS SCORE OF PERI AND POST-MENOPAUSAL DIABETIC PATIENTS. BACKGROUND: YOGIC PRACTICES MAY AID IN THE PREVENTION AND MANAGEMENT OF DIABETES MELLITUS (DM) AND REDUCE CARDIOVASCULAR COMPLICATIONS IN THE POPULATION. THE PRESENT STUDY HAS BEEN UNDERTAKEN TO EVALUATE THE EFFECT OF YOGA THERAPY ON REACTION TIME, BIOCHEMICAL PARAMETERS AND WELLNESS SCORE OF PERI AND POST-MENOPAUSAL DIABETIC PATIENTS. MATERIALS AND METHODS: 15 PERI AND POST-MENOPAUSAL PATIENTS RECEIVING STANDARD MEDICAL TREATMENT FOR TYPE 2 DM WERE RECRUITED AND REACTION TIME AND BIOCHEMICAL INVESTIGATIONS WERE DONE BEFORE AND AFTER A COMPREHENSIVE YOGA THERAPY PROGRAM COMPRISING OF THREE TIMES A WEEK SESSIONS FOR SIX WEEKS. A POST-INTERVENTION, RETROSPECTIVE WELLNESS QUESTIONNAIRE COMPILED BY ACYTER WAS USED TO EVALUATE THE COMPARATIVE FEELINGS OF THE PATIENTS AFTER THE THERAPY PROGRAM. RESULTS: YOGA TRAINING REDUCED AUDITORY REACTION TIME (ART) FROM RIGHT AS WELL AS LEFT HAND, THE DECREASE BEING STATISTICALLY SIGNIFICANT (P<0.05) FOR ART FROM THE RIGHT HAND. THERE WAS A SIGNIFICANT (P<0.01) DECREASE IN FASTING AND POSTPRANDIAL BLOOD GLUCOSE LEVELS AS WELL AS LOW DENSITY LIPOPROTEIN. THE DECREASE IN TOTAL CHOLESTEROL, TRIGLYCERIDES, AND VERY LOW DENSITY LIPOPROTEIN AND INCREASE IN HIGH DENSITY LIPOPROTEIN WAS ALSO STATISTICALLY SIGNIFICANT (P<0.05). ALL THE LIPID RATIOS SHOWED DESIRABLE IMPROVEMENT WITH A DECREASE (P<0.01) OF TC/HDL AND LDL/HDL RATIOS AND INCREASE (P<0.05) IN THE HDL/LDL RATIO. DISCUSSION OR CONCLUSION: SHORTENING OF RT IMPLIES AN IMPROVEMENT IN THE INFORMATION PROCESSING AND REFLEXES AND IS THE FIRST SUCH REPORT IN DIABETIC PATIENTS. THIS HAS CLINICAL SIGNIFICANCE AND IS WORTH FURTHER EXPLORATION WITH WIDER, WELL CONTROLLED, RANDOMIZED STUDIES IN THE DIABETIC POPULATION. CHANGES IN BLOOD GLUCOSE LEVELS MAY BE DUE TO IMPROVED INSULIN SENSITIVITY, DECLINE IN INSULIN RESISTANCE AND INCREASED SENSITIVITY OF THE PANCREATIC B CELLS TO GLUCOSE SIGNALS. YOGA IMPROVED THE 'HEART FRIENDLY' STATUS OF LIPID PROFILE IN OUR SUBJECTS AND AS OUR PARTICIPANTS WERE PERI AND POST-MENOPAUSAL, THE DECREASE IN CARDIOVASCULAR RISK PROFILE IS OF GREATER SIGNIFICANCE. A COMPREHENSIVE YOGA THERAPY PROGRAM HAS THE POTENTIAL TO ENHANCE THE BENEFICIAL EFFECTS OF STANDARD MEDICAL MANAGEMENT OF DIABETES MELLITUS AND CAN BE USED AS AN EFFECTIVE COMPLEMENTARY OR INTEGRATIVE THERAPY PROGRAM. 2012 5 300 27 AN ASSESSMENT OF A SEQUENCE OF YOGA EXERCISES TO PATIENTS WITH ARTERIAL HYPERTENSION. THIS QUASI-EXPERIMENTAL STUDY DESCRIBES THE EFFECTS OF A YOGA SEQUENCE FOLLOWING HEMODYNAMIC AND BIOCHEMICAL PARAMETERS IN PATIENTS WITH HYPERTENSION. THIRTY-THREE VOLUNTEERS PARTICIPATED IN THE STUDY (CONTROL = 16 AND YOGA = 17) FOR FOUR MONTHS. BLOOD PRESSURE MEASUREMENTS, CARDIAC AND RESPIRATORY RATE WERE COLLECTED MONTHLY, WHILE THE BIOCHEMICAL PROFILE WAS TAKEN AT THE BEGINNING AND END OF THE PROGRAM. TO ANALYZE THE DATA, STUDENT'S T TEST AND REPEATED MEASURES ANALYSES WERE PERFORMED. THE YOGA GROUP SHOWED A SIGNIFICANT REDUCTION OF SYSTOLIC BLOOD PRESSURE, HEART AND RESPIRATORY RATE (P < 0.05). AS FOR THE BIOCHEMICAL PROFILE, THE YOGA GROUP SHOWED CORRELATION COEFFICIENTS BETWEEN INITIAL VALUES AND FINAL RESPONSES GREATER THAN THE CONTROL OF FASTING GLUCOSE, TOTAL CHOLESTEROL, LDL-CHOLESTEROL AND TRIGLYCERIDES. THE ELABORATED SEQUENCE PRACTICE PROMOTED SIGNIFICANT CARDIOVASCULAR AND METABOLIC BENEFITS. THE YOGA EXERCISES PERFORMED IN THE PROPOSED SEQUENCE CONSTITUTE COMPLEMENTARY NON-PHARMACOLOGICAL CONTROL OF BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION. 2013 6 823 32 EFFECT OF YOGA ON GLUCOSE CONTROL AND QUALITY OF LIFE IN PATIENTS OF PREDIABETES. OBJECTIVE: THE OBJECTIVE OF THIS STUDY WAS TO EVALUATE EFFECT OF YOGA ON FASTING PLASMA GLUCOSE (FPG), POSTPRANDIAL PLASMA GLUCOSE, AND HEMOGLOBIN A1C (HBA1C) AND ALSO ON QUALITY OF LIFE (QOL). RESEARCH DESIGN AND METHODS: THIS WAS A COHORT STUDY IN WHICH 100 DIAGNOSED CASES OF PREDIABETES WERE RECRUITED FOR DOING SPECIFIC YOGA, AND THEY THEMSELVES ACT AS CONTROL FOR THE STUDY. THE MEASUREMENT AND COMPARISON OF FPG, PRANDIAL PLASMA GLUCOSE (PPG), AND HBA1C WERE DONE AT THREE DIFFERENT TIME INTERVALS, THAT IS, BASELINE, 3 MONTHS, AND AT 6 MONTHS. THE ASSESSMENT OF QOL WAS DONE USING SF-36 SCALE. RESULTS: ONE HUNDRED PREDIABETIC CASES WERE SELECTED FOR THE STUDY IN WHICH IMPAIRED FASTING GLUCOSE (IFG) WAS PRESENT MORE IN YOUNGER POPULATION COMPARED TO IMPAIRED GLUCOSE TOLERANCE (IGT) AND IFG PLUS IGT BOTH OF WHICH ARE MORE PREVALENT IN MIDDLE AGE GROUP. THE YOGA THERAPY WAS FOUND TO HAVE FAVORABLE EFFECT ON FPG, PPG, AND HBA1C ALONG WITH VARIOUS ANTHROPOMETRY MEASURES STUDIED IN THIS STUDY. AFTER ADJUSTING CORRELATION COEFFICIENT FOR VARIOUS ANTHROPOMETRY MEASURES, YOGA WAS FOUND TO BE EFFECTIVE FOR CONTROLLING GLYCEMIC PARAMETERS IN PREDIABETICS. CONCLUSIONS: YOGA IS A TYPE OF EXERCISE KNOWN TO IMPROVE GLYCEMIC CONTROL BY CHANGING ANTHROPOMETRY MEASURES, BUT OUR STUDY AIDS IN KNOWLEDGE ABOUT THE BENEFICIAL EFFECT BEYOND THIS KNOWN FACT THROUGH OTHER MECHANISMS YET TO BE EXPLORED. 2021 7 705 32 EFFECT OF INTEGRATED APPROACH OF YOGA THERAPY ON AUTONOMIC FUNCTIONS IN PATIENTS WITH TYPE 2 DIABETES. BACKGROUND AND OBJECTIVES: INTEGRATED APPROACH OF YOGA THERAPY (IAYT) HAD SHOWN BENEFICIAL EFFECTS IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS (DM). AUTONOMIC DYSFUNCTION IS ONE OF THE MAJOR COMPLICATIONS OF TYPE 2 DM. RESEARCH STUDIES HAVE DEMONSTRATED THAT YOGA CAN MODULATE AUTONOMIC FUNCTIONS. HENCE, THE CURRENT STUDY WAS DESIGNED TO ASSESS THE EFFECT OF IAYT ON AUTONOMIC FUNCTIONS IN TYPE 2 DIABETICS. MATERIALS AND METHODS: 15 PATIENTS OF TYPE 2 DM WITH AGES RANGING FROM 35 TO 60 YEARS WERE RECRUITED FOR THE STUDY. THEY WERE DIAGNOSED WITH TYPE 2 DIABETES FROM 1-YEAR TO 15 YEARS. ASSESSMENTS WERE MADE ON DAY 1 (BEFORE YOGA) AND DAY 7 (AFTER 1-WEEK OF YOGA PRACTICE). HEART RATE VARIABILITY (HRV), BLOOD PRESSURE (BP) RESPONSE TO THE ISOMETRIC HANDGRIP AND HEART RATE RESPONSE TO DEEP BREATHING WERE ASSESSED BEFORE AND AFTER 1-WEEK OF IAYT. RESULTS: THERE WAS A SIGNIFICANT REDUCTION IN FASTING PLASMA GLUCOSE FROM 154.67-130.27 MG/DL (WILCOXON SIGNED RANK TEST, P = 0.029) FOLLOWING 1-WEEK OF IAYT. BP RESPONSE TO ISOMETRIC HAND GRIP IMPROVED SIGNIFICANTLY (WILCOXON SIGNED RANK TEST, P = 0.01). THERE WAS NO STATISTICAL SIGNIFICANT CHANGE IN HRV COMPONENTS AND HEART RATE RESPONSE TO DEEP BREATHING TEST. HOWEVER, THERE WAS A TREND OF INCREASE IN THE LOW FREQUENCY POWER (41.07%), HIGH FREQUENCY POWER (6.29%), TOTAL POWER (5.38%), AND STANDARD DEVIATION OF ALL NN INTERVALS (SDNN) (6.29%). CONCLUSION: THESE FINDINGS SUGGEST THAT, IAYT IMPROVED AUTONOMIC FUNCTIONS IN TYPE 2 DIABETES PATIENTS. 2015 8 926 31 EFFECTIVENESS OF YOGA LIFESTYLE ON LIPID METABOLISM IN A VULNERABLE POPULATION-A COMMUNITY BASED MULTICENTER RANDOMIZED CONTROLLED TRIAL. BACKGROUND: DYSLIPIDEMIA POSES A HIGH RISK FOR CARDIOVASCULAR DISEASE AND STROKE IN TYPE 2 DIABETES (T2DM). THERE ARE NO STUDIES ON THE IMPACT OF A VALIDATED INTEGRATED YOGA LIFESTYLE PROTOCOL ON LIPID PROFILES IN A HIGH-RISK DIABETES POPULATION. METHODS: HERE, WE REPORT THE RESULTS OF LIPID PROFILE VALUES OF 11,254 (YOGA 5932 AND CONTROL 5322) ADULTS (20-70 YEARS) OF BOTH GENDERS WITH HIGH RISK (>/=60 ON INDIAN DIABETES RISK SCORE) FOR DIABETES FROM A NATIONWIDE RURAL AND URBAN COMMUNITY-BASED TWO GROUP (YOGA AND CONVENTIONAL MANAGEMENT) CLUSTER RANDOMIZED CONTROLLED TRIAL. THE YOGA GROUP PRACTICED A VALIDATED INTEGRATED YOGA LIFESTYLE PROTOCOL (DYP) IN NINE DAY CAMPS FOLLOWED BY DAILY ONE-HOUR PRACTICE. BIOCHEMICAL PROFILING INCLUDED GLYCATED HEMOGLOBIN AND LIPID PROFILES BEFORE AND AFTER THREE MONTHS. RESULTS: THERE WAS A SIGNIFICANT DIFFERENCE BETWEEN GROUPS (P < 0.001 ANCOVA) WITH IMPROVED SERUM TOTAL CHOLESTEROL, TRIGLYCERIDES, LOW-DENSITY LIPOPROTEIN, AND HIGH-DENSITY LIPOPROTEIN IN THE YOGA GROUP COMPARED TO THE CONTROL GROUP. FURTHER, THE REGULATORY EFFECT OF YOGA WAS NOTED WITH A SIGNIFICANT DECREASE OR INCREASE IN THOSE WITH HIGH OR LOW VALUES OF LIPIDS, RESPECTIVELY, WITH MARGINAL OR NO CHANGE IN THOSE WITHIN THE NORMAL RANGE. CONCLUSION: YOGA LIFESTYLE IMPROVES AND REGULATES (LOWERED IF HIGH, INCREASED IF LOW) THE BLOOD LIPID LEVELS IN BOTH GENDERS OF PREDIABETIC AND DIABETIC INDIVIDUALS IN BOTH RURAL AND URBAN INDIAN COMMUNITIES. 2021 9 1455 32 INFLUENCE OF TIME OF YOGA PRACTICE AND GENDER DIFFERENCES ON BLOOD GLUCOSE LEVELS IN TYPE 2 DIABETES MELLITUS AND NORMAL HEALTHY ADULTS. BACKGROUND: PREVALENCE OF TYPE 2 DIABETES MELLITUS (T2DM) IS INCREASING WORLDWIDE. MANY STUDIES HAVE DEMONSTRATED THE EFFECTIVENESS OF YOGA IN IMPROVING GLYCAEMIC CONTROL, WHEREAS NO STUDIES ARE AVAILABLE SHOWING THE IMPACT OF TIME OF PRACTICE ON GLUCOSE LEVELS. THE CURRENT STUDY EXPLORES THE EFFECT OF TIME OF YOGA PRACTICE ON GLUCOSE LEVELS IN COMMUNITY-DWELLING ADULTS WITH AND WITHOUT T2DM. MATERIALS AND METHODS: A TOTAL OF 189 SUBJECTS WITH T2DM AND 121 SUBJECTS WITHOUT T2DM UNDERWENT A 10-DAY YOGA PROGRAM WHICH INCLUDES PRACTICAL AND THEORY LECTURE SESSIONS FOR 60MIN EVERY DAY, EITHER IN THE MORNING OR EVENING. BASELINE AND POST-INTERVENTION ASSESSMENTS OF FASTING PLASMA GLUCOSE (FPG) WERE MEASURED ON DAY-1 AND DAY-10, RESPECTIVELY. DATA ANALYSIS WERE DONE USING STATISTICAL PACKAGE FOR THE SOCIAL SCIENCES (SPSS), VERSION 16. RESULTS: RESULTS OF THE STUDY SHOWED THAT IN INDIVIDUALS WITH T2DM, A SIGNIFICANTLY HIGHER REDUCTION IN FPG WAS OBSERVED WHILE PRACTICING YOGA IN THE EVENING SESSIONS THAN IN THE MORNING SESSIONS. LIKEWISE, A SIGNIFICANT REDUCTION IN FPG WAS OBSERVED ONLY IN WOMEN WHO PRACTICED YOGA IN THE EVENING THAN IN THE MORNING, IN NON-DIABETIC HEALTHY INDIVIDUALS, WHILE THE REDUCTION WAS NOT STATISTICALLY SIGNIFICANT IN MEN. CONCLUSION: RESULTS OF THIS STUDY SUGGEST THAT REDUCTION IN FPG LEVEL WAS BETTER WHILE PRACTICING YOGA IN EVENING THAN MORNING. SIMILARLY, WOMEN HAD A BETTER REDUCTION IN BLOOD GLUCOSE LEVEL THAN MEN. 2018 10 39 35 A BRIEF BUT COMPREHENSIVE LIFESTYLE EDUCATION PROGRAM BASED ON YOGA REDUCES RISK FACTORS FOR CARDIOVASCULAR DISEASE AND DIABETES MELLITUS. OBJECTIVES: THE OBJECTIVE OF THE STUDY WAS TO STUDY THE SHORT-TERM IMPACT OF A BRIEF LIFESTYLE INTERVENTION BASED ON YOGA ON SOME OF THE BIOCHEMICAL INDICATORS OF RISK FOR CARDIOVASCULAR DISEASE AND DIABETES MELLITUS. DESIGN: THE VARIABLES OF INTEREST WERE MEASURED AT THE BEGINNING (DAY 1) AND END (DAY 10) OF THE INTERVENTION USING A PRE-POST DESIGN. SETTING: THE STUDY IS THE RESULT OF OPERATIONAL RESEARCH CARRIED OUT IN OUR INTEGRAL HEALTH CLINIC (IHC). THE IHC IS AN OUTPATIENT FACILITY WHICH CONDUCTS 8-DAY LIFESTYLE MODIFICATION PROGRAMS BASED ON YOGA FOR PREVENTION AND MANAGEMENT OF CHRONIC DISEASE. A NEW COURSE BEGINS EVERY ALTERNATE WEEK OF THE YEAR. SUBJECTS: THE STUDY IS BASED ON DATA COLLECTED ON 98 SUBJECTS (67 MALE, 31 FEMALE), AGES 20-74 YEARS, WHO ATTENDED ONE OF OUR PROGRAMS. THE SUBJECTS WERE A HETEROGENEOUS GROUP OF PATIENTS WITH HYPERTENSION, CORONARY ARTERY DISEASE, DIABETES MELLITUS, AND A VARIETY OF OTHER ILLNESSES. INTERVENTION: THE INTERVENTION CONSISTED OF ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), RELAXATION TECHNIQUES, GROUP SUPPORT, INDIVIDUALIZED ADVICE, LECTURES AND FILMS ON THE PHILOSOPHY OF YOGA AND THE PLACE OF YOGA IN DAILY LIFE, MEDITATION, STRESS MANAGEMENT, NUTRITION, AND KNOWLEDGE ABOUT THE ILLNESS. OUTCOME MEASURES: THE OUTCOME MEASURES WERE FASTING PLASMA GLUCOSE AND SERUM LIPOPROTEIN PROFILE. THESE VARIABLES WERE DETERMINED IN FASTING BLOOD SAMPLES, TAKEN ON THE FIRST AND LAST DAY OF THE COURSE. RESULTS: FASTING PLASMA GLUCOSE, SERUM TOTAL CHOLESTEROL, LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL, VERY- LDL CHOLESTEROL, THE RATIO OF TOTAL CHOLESTEROL TO HIGH DENSITY LIPOPROTEIN (HDL) CHOLESTEROL, AND TOTAL TRIGLYCERIDES WERE SIGNIFICANTLY LOWER, AND HDL CHOLESTEROL SIGNIFICANTLY HIGHER, ON THE LAST DAY OF THE COURSE COMPARED TO THE FIRST DAY OF THE COURSE. THE CHANGES WERE MORE MARKED IN SUBJECTS WITH HYPERGLYCEMIA OR HYPERCHOLESTEROLEMIA. CONCLUSIONS: THE OBSERVATIONS SUGGEST THAT A SHORT LIFESTYLE MODIFICATION AND STRESS MANAGEMENT EDUCATION PROGRAM LEADS TO FAVORABLE METABOLIC EFFECTS WITHIN A PERIOD OF 9 DAYS. 2005 11 1928 32 ROLE OF YOGA IN DIABETES. THE SCIENCE OF YOGA IS AN ANCIENT ONE. IT IS A RICH HERITAGE OF OUR CULTURE. SEVERAL OLDER BOOKS MAKE A MENTION OF THE USEFULNESS OF YOGA IN THE TREATMENT OF CERTAIN DISEASES AND PRESERVATION OF HEALTH IN NORMAL INDIVIDUALS. THE EFFECT OF YOGIC PRACTICES ON THE MANAGEMENT OF DIABETES HAS NOT BEEN INVESTIGATED WELL. WE CARRIED OUT WELL DESIGNED STUDIES IN NORMAL INDIVIDUALS AND THOSE WITH DIABETES TO ASSESS THE ROLE OF YOGIC PRACTICES ON GLYCAEMIC CONTROL, INSULIN KINETICS, BODY COMPOSITION EXERCISE TOLERANCE AND VARIOUS CO-MORBIDITIES LIKE HYPERTENSION AND DYSLIPIDEMIA. THESE STUDIES WERE BOTH SHORT TERM AND LONG-TERM. THESE STUDIES HAVE CONFIRMED THE USEFUL ROLE OF YOGA IN THE CONTROL OF DIABETES MELLITUS. FASTING AND POSTPRANDIAL BLOOD GLUCOSE LEVELS CAME DOWN SIGNIFICANTLY. GOOD GLYCAEMIC STATUS CAN BE MAINTAINED FOR LONG PERIODS OF TIME. THERE WAS A LOWERING OF DRUG REQUIREMENT AND THE INCIDENCE OF ACUTE COMPLICATIONS LIKE INFECTION AND KETOSIS WAS SIGNIFICANTLY REDUCED. THERE WERE SIGNIFICANT CHANGES IN THE INSULIN KINETICS AND THOSE OF COUNTER-REGULATORY HORMONES LIKE CORTISOL. THERE WAS A DECREASE IN FREE FATTY ACIDS. THERE WAS AN INCREASE IN LEAN BODY MASS AND DECREASE IN BODY FAT PERCENTAGE. THE NUMBER OF INSULIN RECEPTORS WAS ALSO INCREASED. THERE WAS AN IMPROVEMENT IN INSULIN SENSITIVITY AND DECLINE IN INSULIN RESISTANCE. ALL THESE SUGGEST THAT YOGIC PRACTICES HAVE A ROLE EVEN IN THE PREVENTION OF DIABETES. THERE IS A BENEFICIAL EFFECT ON THE CO-MORBID CONDITIONS LIKE HYPERTENSION AND DYSLIPIDEMIA. 2007 12 2295 28 THERAPEUTIC POTENTIAL OF YOGA PRACTICES IN MODIFYING CARDIOVASCULAR RISK PROFILE IN MIDDLE AGED MEN AND WOMEN. AIMS OF STUDY: TO STUDY EFFECT OF YOGA ON THE PHYSIOLOGICAL, PSYCHOLOGICAL WELL BEING, PSYCHOMOTOR PARAMETER AND MODIFYING CARDIOVASCULAR RISK FACTORS IN MILD TO MODERATE HYPERTENSIVE PATIENTS. METHODS: TWENTY PATIENTS (16 MALES, 4 FEMALES) IN THE AGE GROUP OF 35 TO 55 YEARS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION UNDERWENT YOGIC PRACTICES DAILY FOR ONE HOUR FOR THREE MONTHS. BIOCHEMICAL, PHYSIOLOGICAL AND PSYCHOLOGICAL PARAMETERS WERE STUDIED PRIOR AND FOLLOWING PERIOD OF THREE MONTHS OF YOGA PRACTICES, BIOCHEMICAL PARAMETERS INCLUDED, BLOOD GLUCOSE, LIPID PROFILE, CATECHOLMINES, MDA, VIT. C CHOLINESTERASE AND URINARY VMA. PSYCHOLOGICAL EVALUATION WAS DONE BY USING PERSONAL ORIENTATION INVENTORY AND SUBJECTIVE WELL BEING. RESULTS: RESULTS SHOWED DECREASE IN BLOOD PRESSURE AND DRUG SCORE MODIFYING RISK FACTORS, I.E. BLOOD GLUCOSE, CHOLESTEROL AND TRIGLYCERIDES DECREASED OVERALL IMPROVEMENT IN SUBJECTIVE WELL BEING AND QUALITY OF LIFE. THERE WAS DECREASE IN VMA CATECHOLAMINE, AND DECREASE MDA LEVEL SUGGESTIVE DECREASE SYMPATHETIC ACTIVITY AND OXIDANT STRESS. CONCLUSION: YOGA CAN PLAY AN IMPORTANT ROLE IN RISK MODIFICATION FOR CARDIOVASCULAR DISEASES IN MILD TO MODERATE HYPERTENSION. 2002 13 1849 39 QUASI PROSPECTIVE COMPARATIVE STUDY ON EFFECT OF YOGA AMONG PREDIABETICS ON PROGRESSION OF CARDIOVASCULAR RISK FACTORS. INTRODUCTION: PREDIABETIC PATIENTS HAVE HIGHER RISK FOR CARDIOVASCULAR DISEASES, WHICH FURTHER INCREASES THE RATE OF MORTALITY. REASON FOR THE RATE OF INCREASE MAY BE LACK OF OBSERVATION, FOLLOW-UP PROGRAMS, AND SELF-AWARENESS ABOUT THE CONDITIONS OF DISEASE. LIFESTYLE INTERVENTIONS SUCH AS YOGA CAN PROVE TO BE A BENEFICIAL NONPHARMACOLOGIC INTERVENTION IN PREVENTING PROGRESSION OF PREDIABETES TO TYPE 2 DIABETES. THIS STUDY HIGHLIGHTS IMPORTANCE OF SHORT-TERM INTERVENTION, I.E., YOGA IN PREDIABETIC PATIENTS AND USE IT AS A TOOL FOR PRIMARY PREVENTION OF DIABETES. METHODS: THIS WAS AN INTERVENTIONAL STUDY AMONG ADULTS AGED 30-50 YEARS IN RUHS COLLEGE OF MEDICAL SCIENCES AND ASSOCIATED RUKMANI DEVI BENI PRASAD JAIPURIA HOSPITAL IN JAIPUR CITY. THE DESIGN OF STUDY WAS QUASI PROSPECTIVE COMPARATIVE STUDY. A TOTAL OF 102 PREDIABETIC PATIENTS OF AGE GROUP 30-50 YEARS WERE RECRUITED FROM JAIPURIA HOSPITAL. THESE WERE DIVIDED INTO TWO GROUPS: STUDY GROUP (GROUP A, N = 51) WERE ENGAGED IN YOGA SESSION AND CONTROL GROUP (B, N = 51) NOT PERFORMED ANY YOGA SESSION. RESULTS: YOGA INTERVENTION RESULTED IN A SIGNIFICANT DECLINE IN BLOOD GLUCOSE (P < 0.001), GLYCATED HEMOGLOBIN (P < 0.01), LIPID PROFILE CHOLESTEROL (P < 0.01), TRIGLYCERIDE (P < 0.01), AND LOW-DENSITY LIPOPROTEIN (P < 0.01), BUT HIGH-DENSITY LIPOPROTEIN (P < 0.02) AND VERY LOW-DENSITY LIPOPROTEIN INCREASE (P < 0.03) BUT NOT STATISTICALLY SIGNIFICANT RELATIVE TO THE CONTROL GROUP. CONCLUSION: SHORT-TERM YOGA INTERVENTION IS HELPFUL IN THE CONTROL OF GLYCEMIC PARAMETERS LIKE BLOOD GLUCOSE, GLYCATED HEMOGLOBIN AND LIPID PROFILE IN PREDIABETIC PATIENTS. THIS PRELIMINARY STUDY INDICATES THAT A YOGA PROGRAM WOULD BE A POSSIBLE RISK REDUCTION OPTION FOR ADULTS AT HIGH RISK FOR TYPE 2 DIABETES. IN ADDITION, YOGA HOLDS PROMISE AS AN APPROACH TO REDUCING CARDIOMETABOLIC RISK FACTORS AND INCREASING EXERCISE SELF-EFFICACY FOR PREDIABETICS PERFORMING YOGA. 2019 14 2153 21 THE EFFECTS OF SUDARSHAN KRIYA YOGA ON SOME PHYSIOLOGICAL AND BIOCHEMICAL PARAMETERS IN MILD HYPERTENSIVE PATIENTS. AN OPEN LABEL INTERVENTION STUDY WAS UNDERTAKEN ON 26 MILD HYPERTENSIVES AND 26 APPARENTLY HEALTHY ADULTS (30-60 Y), FOR THE EFFECT OF SUDARSHAN KRIYA YOGA PRACTICE FOR TWO MONTHS AS COMPLEMENTARY THERAPY. IN THE HYPERTENSIVES, THERE WAS A SIGNIFICANT DECREASE IN DIASTOLIC BLOOD PRESSURE (P < 0.01), SERUM UREA (P < 0.01) AND PLASMA MDA (MALONDIALDEHYDE ADDUCTS) AS OXIDATIVE STRESS MARKER (P < 0.05). OTHER PARAMETERS; VIZ.; PLASMA LEVELS OF CHOLESTEROL, TRIGLYCERIDES, GLUCOSE, DID NOT CHANGE SIGNIFICANTLY (P > 0.1). THE PATTERN OF CHANGE IN MOST OF THE STUDY PARAMETERS WAS SUCH THAT VALUES ABOVE NORMAL RANGE WERE LOWERED BUT VALUES WITHIN NORMAL RANGE WERE UNALTERED. THE ACTION OF YOGA ON DIASTOLIC BLOOD PRESSURE, MALONDIALDEHYDE ADDUCTS AND KIDNEY FUNCTION IN HYPERTENSIVES WAS OF COUNTERACTIVE NATURE AND FELT TO BE DISTINCTLY DIFFERENT THAN THE EFFECT OF DRUGS. 2011 15 662 26 EFFECT OF 3-MONTH YOGA ON OXIDATIVE STRESS IN TYPE 2 DIABETES WITH OR WITHOUT COMPLICATIONS: A CONTROLLED CLINICAL TRIAL. OBJECTIVE: TO ASSESS THE EFFECT OF YOGA ON ANTHROPOMETRY, BLOOD PRESSURE, GLYCEMIC CONTROL, AND OXIDATIVE STRESS IN TYPE 2 DIABETIC PATIENTS ON STANDARD CARE IN COMPARISON WITH STANDARD CARE ALONE. RESEARCH DESIGN AND METHODS: THE STUDY INVOLVED 123 PATIENTS STRATIFIED ACCORDING TO GROUPS WITH MICROVASCULAR COMPLICATIONS, MACROVASCULAR COMPLICATIONS, AND PERIPHERAL NEUROPATHY AND WITHOUT COMPLICATIONS AND ASSIGNED TO RECEIVE EITHER STANDARD CARE OR STANDARD CARE ALONG WITH ADDITIONAL YOGA FOR 3 MONTHS. RESULTS: IN COMPARISON WITH STANDARD CARE ALONE, YOGA RESULTED IN SIGNIFICANT REDUCTION IN BMI, GLYCEMIC CONTROL, AND MALONDIALDEHYDE AND INCREASE IN GLUTATHIONE AND VITAMIN C. THERE WERE NO DIFFERENCES IN WAIST CIRCUMFERENCE, WAIST-TO-HIP RATIO, BLOOD PRESSURE, VITAMIN E, OR SUPEROXIDE DISMUTASE IN THE YOGA GROUP AT FOLLOW-UP. CONCLUSIONS: YOGA CAN BE USED AS AN EFFECTIVE THERAPY IN REDUCING OXIDATIVE STRESS IN TYPE 2 DIABETES. YOGA IN ADDITION TO STANDARD CARE HELPS REDUCE BMI AND IMPROVE GLYCEMIC CONTROL IN TYPE 2 DIABETIC PATIENTS. 2011 16 435 29 CARDIOPULMONARY AND METABOLIC EFFECTS OF YOGA IN HEALTHY VOLUNTEERS. BACKGROUND: YOGA THE SPIRITUAL UNION OF MIND WITH THE DIVINE INTELLIGENCE OF THE UNIVERSE AIMS TO LIBERATE A HUMAN BEING FROM CONFLICTS OF BODY-MIND DUALITY. BENEFICIAL CARDIOVASCULAR AND PULMONARY EFFECTS OF YOGA ARE IN PAR WITH AEROBIC EXERCISE, EVEN AMOUNTING TO REPLACE THE EXERCISE MODEL. WE CONDUCTED AN INTERVENTIONAL STUDY IN HEALTHY VOLUNTEERS, TO ANALYZE THE IMPACT OF SHORT-TERM YOGA TRAINING ON CARDIOVASCULAR, PULMONARY, AUTONOMIC FUNCTION TESTS, LIPID PROFILE, AND THYROID FUNCTION TESTS. MATERIALS AND METHODS: A SAMPLE OF FIFTY NEW RECRUITS ATTENDING THE DISTRICT YOGA CENTER WAS SUBJECT TO 75 MIN YOGA PRACTICE A DAY FOR 41 DAYS. BASAL VALUES OF CARDIOVASCULAR, PULMONARY, AUTONOMIC FUNCTION TESTS, LIPID PROFILE, AND THYROID FUNCTION TESTS WERE RECORDED BEFORE YOGA TRAINING AND WERE REASSESSED FOR POSTYOGA CHANGES AFTER 41 DAYS. RESULTS: AFTER YOGA PRACTICE THERE WAS A SIGNIFICANT REDUCTION IN THE RESTING HEART RATE, SYSTOLIC BLOOD PRESSURE, DIASTOLIC BLOOD PRESSURE, AND MEAN BLOOD PRESSURE OF THE PARTICIPANTS. EFFECTS ON AUTONOMIC FUNCTION TESTS WERE VARIABLE AND INCONCLUSIVE. THERE WAS A SIGNIFICANT INCREASE IN FORCED VITAL CAPACITY, FORCED EXPIRATORY VOLUME IN 1 S, AND PEAK EXPIRATORY FLOW RATE AFTER YOGA. A SIGNIFICANT REDUCTION IN BODY MASS INDEX WAS OBSERVED. EFFECTS ON METABOLIC PARAMETERS WERE PROMISING WITH A SIGNIFICANT REDUCTION IN FASTING BLOOD SUGAR LEVEL, SERUM TOTAL CHOLESTEROL, SERUM TRIGLYCERIDES SERUM LOW-DENSITY LIPOPROTEIN LEVELS, AND SIGNIFICANT INCREASE IN HIGH-DENSITY LIPOPROTEIN. THERE WAS NO SIGNIFICANT CHANGE IN THYROID FUNCTION TESTS AFTER YOGA. CONCLUSION: SHORT-TERM YOGA PRACTICE HAS NO EFFECT ON THYROID FUNCTIONS. YOGA PRACTICE WAS FOUND BENEFICIAL IN MAINTAINING PHYSIOLOGICAL MILIEU PERTAINING TO CARDIOVASCULAR AND OTHER METABOLIC PARAMETERS. 2017 17 1104 31 EFFECTS OF YOGA VERSUS SHAM YOGA ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS: A SINGLE-BLINDED RANDOMIZED PILOT STUDY. STUDIES HAVE SHOWN A BENEFICIAL ROLE OF YOGA IN TRE A T I N G TYPE 2 DIABETES MELLITUS. THE PRESENT STUDY PROCEEDS IN THE FIELD BY PROVIDING AN ACTIVE CONTROL. WE AIMED TO EVALUATE THE EFFECT OF 3 MONTHS OF YOGA ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS. FORTY PARTICIPANTS WERE RANDOMIZED TO RECEIVE EITHER YOGA (N = 20) OR SHAM YOGA (N = 20) AS A CONTROL. YOGA INCLUDED POSTURES AND BREATHING EXERCISES, AND NONAEROBIC STRETCHING EXERCISE COMPRISED THE CONTROL. SIGNIFICANT WITHIN-GROUP DIFFERENCES IN MALONDIALDEHYDE, VITAMIN C, SUPEROXIDE DISMUTASE, FASTING BLOOD GLUCOSE, GLYCOSYLATED HEMOGLOBIN, BODY MASS INDEX, WAIST CIRCUMFERENCE, AND BLOOD PRESSURE WERE EVIDENT IN BOTH GROUPS. YOGA PARTICIPANTS HAD SIGNIFICANTLY GREATER IMPROVEMENT IN REDUCED GLUTATHIONE COMPARED TO CONTROLS. NO SIGNIFICANT DIFFERENCES BETWEEN GROUPS WERE OBSERVED IN ANY OTHER OUTCOME VARIABLES. YOGA AND SHAM YOGA HAD IDENTICAL EFFECTS ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS. LEVELS OF REDUCED GLUTATHIONE IMPROVED ONLY IN THE YOGA GROUP. THIS RESEARCH NEEDS TO BE CONFIRMED BY LARGER AND SUFFICIENTLY POWERED STUDIES. 2020 18 1378 26 IMPACT OF INDIVIDUALIZED YOGA THERAPY ON PERCEIVED QUALITY OF LIFE PERFORMANCE ON COGNITIVE TASKS AND DEPRESSION AMONG TYPE II DIABETIC PATIENTS. CONTEXT: AN INDIVIDUALIZED APPROACH OF PROVIDING YOGA SUPPORT CAN ADDRESS MANY OF THE DISEASE-RELATED CONCERNS INDICATED IN THE MANAGEMENT OF DIABETES, SPECIFICALLY THE IMPACT ON OTHER LIFE ACTIVITIES AND LONG-TERM FUNCTIONAL WELLBEING. AIM: TO ANALYZE THE ROLE OF REGULAR YOGA PRACTICE AS A SELF-MANAGEMENT APPROACH TO ACHIEVE GLYCEMIC CONTROL AND PSYCHOLOGICAL WELLBEING IN TYPE II DIABETIC PATIENTS. METHODS: NINETY-ONE SUBJECTS OF BOTH SEXES RESPONDED TO THE ANNOUNCEMENT AND CONSENTED TO PARTICIPATE IN THE STUDY. THIS WAS A SINGLE GROUP, BEFORE AND AFTER YOGA EVALUATION WITHOUT CONTROL COMPARISON. THE FASTING AND POSTPRANDIAL BLOOD SUGAR, GLYCOSYLATED HEMOGLOBIN (HBA1C), COGNITIVE TASKS, DEPRESSION, COGNITIVE FAILURE, AND DIABETIC-RELATED QUALITY OF LIFE (QOL) WERE MEASURED AS PRETEST. THE SUBJECTS UNDERWENT ONE-TO-ONE INDIVIDUALIZED YOGA THERAPY SESSIONS, WHICH INCLUDED 12 SUPERVISED SESSIONS SPREAD OVER A 3-MONTH PERIOD. THE POSTTEST DATA WERE ANALYZED USING PAIRED T-TEST AND WILCOXON PAIRED RANK TEST. RESULTS: SHOWED SIGNIFICANT REDUCTION IN FASTING BLOOD SUGAR. QOL OF THE DIABETIC PATIENTS HAD IMPROVED SIGNIFICANTLY. THERE WAS A SIGNIFICANT REDUCTION IN THE FREQUENCY (MEAN DIFFERENCE OF 7.58, P > 0.01) OF DEPRESSIVE SYMPTOMS AND INTENSITY OF DEPRESSION (MEAN DIFFERENCE 1.66, P > 0.05). CONCENTRATION AND ATTENTION SPAN IMPROVED SIGNIFICANTLY AND MEAN DISCREPANCY SCORE REDUCED (MEAN DIFFERENCE 3.42, P > 0.01). THERE WERE NO MARKED CHANGES IN THE POSTPRANDIAL BLOOD SUGAR AND HBA1C. CONCLUSION: YOGA PRACTICE ENHANCES THE SUBJECTIVE WELLBEING, QOL, IMPROVES MOOD AND CONCENTRATION, AND FACILITATES ACHIEVEMENT OF ADEQUATE GLYCEMIC CONTROL AMONG TYPE II DIABETIC PATIENTS. 2016 19 1491 33 INTERLEUKIN-6, VITAMIN D & DIABETES RISK-FACTORS MODIFIED BY A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN OVERWEIGHT/OBESE INDIVIDUALS. BACKGROUND & OBJECTIVES: SEVERAL DIABETES PREVENTION PROGRAMMES HAVE DEMONSTRATED A REDUCTION IN INCIDENCE OF DIABETES IN INDIVIDUALS WITH PREDIABETES THROUGH WEIGHT LOSS. SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION PROGRAMMES HAVE ALSO BEEN SHOWN TO BE EFFICACIOUS IN WEIGHT LOSS. THIS STUDY WAS UNDERTAKEN TO INVESTIGATE IF INTERLEUKIN (IL)-6, VITAMIN D, NEOPTERIN, VASPIN, AND DIABETES RISK FACTORS CAN BE MODIFIED BY A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN OVERWEIGHT/OBESE SUBJECTS. METHODS: IN THIS PILOT STUDY, 34 OVERWEIGHT/OBESE [BODY MASS INDEX (BMI) >/= 23 TO <35 KG/M [2] PER ASIAN CUT-OFF VALUES] INDIVIDUALS WERE ENROLLED, AND RECEIVED DIRECTLY SUPERVISED INTERVENTION FOR 10 DAYS. THEREAFTER, THEY WERE ADVISED TO FOLLOW THIS YOGA-BASED LIFESTYLE AT HOME FOR ONE MONTH, AND WERE REASSESSED FOR STUDY VARIABLES AT DAY 30. RESULTS: THERE WAS A REDUCTION FROM BASELINE TO DAY 10 IN WEIGHT ( P <0.001), BMI ( P <0.001), WAIST/HIP-RATIO ( P <0.05), BLOOD GLUCOSE ( P <0.01), AND A SIGNIFICANT IMPROVEMENT IN LIPID PROFILE. THERE WAS A DECREASE IN MEDIAN FASTING INSULIN ( P <0.05), HOMEOSTATIC MODEL ASSESSMENT-INSULIN RESISTANCE ( P <0.01), AND IL-6 ( PP <0.05). A NON-SIGNIFICANT INCREASE IN 25-OH-VITAMIN D, AND A DECREASE IN NEOPTERIN AND VASPIN WERE OBSERVED. TWENTY SUBJECTS RETURNED FOR FOLLOW UP ASSESSMENTS. AT DAY 30, WEIGHT LOSS WAS SUSTAINED WHILE SYSTOLIC BLOOD PRESSURE ALSO SHOWED REDUCTION ( P <0.05). CHANGES IN VITAMIN D LEVELS WERE SIGNIFICANTLY AND NEGATIVELY CORRELATED WITH CHANGES IN WEIGHT, BMI AND FASTING BLOOD GLUCOSE, AND POSITIVELY WITH CHANGE IN HIGH DENSITY LIPOPROTEIN. CHANGES IN BODY WEIGHT AND BMI SIGNIFICANTLY AND POSITIVELY CORRELATED WITH INSULIN. CHANGES IN IL-6 LEVELS POSITIVELY AND SIGNIFICANTLY CORRELATED WITH CHANGE IN NEOPTERIN LEVELS. INTERPRETATION & CONCLUSIONS: THE FINDINGS SHOWED THAT IL-6, VITAMIN D, AND DIABETES RISK FACTORS WERE FAVOURABLY MODIFIED BY A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN OBESITY. THIS STUDY ALSO HIGHLIGHTED THE CHALLENGES IN COMPLIANCE ASSOCIATED WITH THE FOLLOW UP OF SUBJECTS FOLLOWING AN AGGRESSIVE SUPERVISED INTERVENTION OF 10 DAYS. 2015 20 796 32 EFFECT OF YOGA INTERVENTION ON BIOCHEMICAL, OXIDATIVE STRESS MARKERS, INFLAMMATORY MARKERS AND SLEEP QUALITY AMONG SUBJECTS WITH TYPE 2 DIABETES IN SOUTH INDIA: RESULTS FROM THE SATYAM PROJECT. AIMS: THE AIM OF THIS STUDY WAS TO INVESTIGATE THE EFFECT OF YOGA INTERVENTION ON THE BIOCHEMICAL, OXIDATIVE STRESS MARKERS AND INFLAMMATORY MARKERS AND SLEEP QUALITY AMONG SUBJECTS WITH TYPE 2 DIABETES. METHODS: SUBJECTS WITH TYPE 2 DIABETES ATTENDING A TERTIARY CARE CENTRE FOR DIABETES DURING FEB 2017 TO OCT 2019 IN CHENNAI, INDIA WERE RANDOMLY ASSIGNED TO TWO DIFFERENT GROUPS. GROUP1(NON-YOGA) (N = 150) WAS ADVISED ON SIMPLE PHYSICAL EXERCISES WHEREAS GROUP2(YOGA) (N = 150) WAS TRAINED AND ADVISED TO DO YOGASANAS WITH STATIC LOOSENING EXERCISES FOR 50 MIN FOR 5 DAYS IN A WEEK. BOTH THE GROUPS WERE FOLLOWED UP FOR A PERIOD OF 3 MONTHS. ANTHROPOMETRIC, BIOCHEMICAL, OXIDATIVE STRESS MARKERS, INFLAMMATORY MARKERS AND SLEEP QUALITY WERE ASSESSED AT BASELINE AND AFTER FOLLOW UP. RESULTS: THERE WAS A SIGNIFICANT REDUCTION IN BMI, BLOOD GLUCOSE LEVELS, HBA1C, LIPID LEVELS, IL6, TNFALPHA AND TBARS IN YOGA GROUP AS COMPARED TO NON-YOGA GROUP. THERE WAS MARKED IMPROVEMENT IN THE LEVELS OF ADIPONECTIN, PTGIS AND SLEEP QUALITY AMONG SUBJECTS PRACTISING YOGASANAS. CONCLUSION: REGULAR PRACTICE OF YOGASANAS IMPROVED GLYCAEMIC CONTROL, OXIDATIVE STRESS, INFLAMMATORY RESPONSE AND SLEEP QUALITY AMONG SUBJECTS WITH TYPE 2 DIABETES. HENCE, YOGASANAS CAN BE USED AS AN ADJUVANT THERAPY FOR MANAGING TYPE 2 DIABETES. 2021